Clinical Trial: Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase 3, Multi-Center, Single-Arm, Open-Label Study For The Safety And Efficacy Of Mistletoe Extract (AbnobaViscum® Injection) In Malignant Pleural Effusions

Brief Summary: Phase 3, non-randomized, Multicenter, single arm study to assess efficacy and safety of Abnoba viscum F 20mg in patients with malignant pleural effusion

Detailed Summary:
Sponsor: Abnoba Korea

Current Primary Outcome: Efficacy [ Time Frame: 4 weeks ]

Efficacy assessment of pleural effusion with Chest X-ray after 4 weeks of final treatment


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Abnoba Korea

Dates:
Date Received: July 14, 2014
Date Started: January 2011
Date Completion:
Last Updated: July 21, 2014
Last Verified: July 2014